<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Long-term exposure to <z:chebi fb="56" ids="16716">benzene</z:chebi> vapors is associated with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> such as <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>CD(1) male mice were randomly assigned to six groups: 1B(10), 1B(15), 1B(20), 2B(10), 2B(15), and 2B(20.) 1B mice were administered 2 ml/kg (1940 mg/kg) subcutaneous injection (in the dorsal region) of <z:chebi fb="56" ids="16716">benzene</z:chebi> 5 days a week, and 2B mice were exposed 3 days a week (Monday, Wednesday and Friday) until a total of 10, 15 and 20 doses were completed </plain></SENT>
<SENT sid="2" pm="."><plain>About 48 h after treatment completion, leukocyte, erythrocyte, and bone marrow cells were counted, and spleen histopathology was analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>1B(15) and 1B(20) mice showed <z:hpo ids='HP_0001254'>lethargy</z:hpo> and <z:hpo ids='HP_0000737'>irritability</z:hpo>, 80% body and 42% spleen <z:hpo ids='HP_0001824'>weight loss</z:hpo> (P&lt;0.001), while body and spleen <z:hpo ids='HP_0001824'>weight loss</z:hpo> were less severe in 2B mice (12 and 48%, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>After exposure to 20 benzene doses, 1B(20) and 2B(20) mice showed decreased <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> concentrations, and erythrocyte, leukocyte and bone marrow cell counts (37, 34, 80 and 50%, respectively in group 1B(20); P&lt;0.001; and 12, 48, 62 and 62%, respectively in group 2B(20)) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> occurred only in group 2B </plain></SENT>
<SENT sid="6" pm="."><plain>Both <z:chebi fb="56" ids="16716">benzene</z:chebi>-treatment schemes caused <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, however, the disease was masked by spleen toxicity in group 1B </plain></SENT>
<SENT sid="7" pm="."><plain>Scheme 2 allowed mice survival and caused less non-hematological effects </plain></SENT>
<SENT sid="8" pm="."><plain>We establish here a reproducible and inexpensive experimental model to induce <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in mice by subcutaneous injection of 2 ml/kg <z:chebi fb="56" ids="16716">benzene</z:chebi>, using two short-term treatment schemes </plain></SENT>
</text></document>